An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Substances which lower blood glucose levels.

Sulfonylurea compounds are a class of medications used in the treatment of diabetes mellitus type 2 that promote insulin secretion from pancreatic beta-cells by closing ATP-sensitive potassium channels in their membranes.